Skip to main content
رجوع
Watch Compare

NEUROONE MEDICAL TECHNOLOGIES Corp

جودة البيانات: 100%
NMTC
Nasdaq Manufacturing Measuring & Analyzing Instruments
KWD 0.74
▲ KWD 0.02 (2.43%)
القيمة السوقية: 37.39 M
السعر
KWD 0.74
القيمة السوقية
37.39 M
نطاق اليوم
KWD 0.72 — KWD 0.77
نطاق 52 أسبوعًا
KWD 0.42 — KWD 1.16
حجم التداول
48,950
فتح KWD 0.76
متوسط 50 يوم / 200 يوم
KWD 0.78
4.92% below
متوسط 50 يوم / 200 يوم
KWD 0.79
6.38% below

Quick Summary

النقاط الرئيسية

Revenue grew 167.32% annually over 5 years — strong growth
Negative free cash flow of -6.28 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.85%
Capital efficient — spends only 1.41% of revenue on capex

النمو

Revenue Growth (5Y)
167.32%
أعلى من متوسط القطاع (9.35%)
Revenue (1Y)163.47%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-93.67%
أقل من متوسط القطاع (-51.02%)
ROIC-72.27%
Net Margin-78.34%
Op. Margin-87.71%

الأمان

Debt / Equity
N/A
Current Ratio6.41
Interest CoverageN/A

التقييم

PE (TTM)
-5.48
أقل من متوسط القطاع (-1.98)
P/B Ratio5.84
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -5.5 -2.0
P/B 5.8 5.1
ROE % -93.7 -51.0
Net Margin % -78.3 -150.2
Rev Growth 5Y % 167.3 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 163.47% Revenue Growth (3Y) 115.86%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 167.32% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 8.72 M Net Income (TTM) -6.83 M
ROE -93.67% ROA -70.41%
Gross Margin 54.87% Operating Margin -87.71%
Net Margin -78.34% Free Cash Flow (TTM) -6.28 M
ROIC -72.27% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6.41
Interest Coverage N/A Asset Turnover 0.90
Working Capital 6.81 M Tangible Book Value 6.36 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5.48 Forward P/E N/A
P/B Ratio 5.84 P/S Ratio 4.29
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -16.81%
Market Cap 37.39 M Enterprise Value 33.83 M
Per Share
EPS (Diluted TTM) -0.18 Revenue / Share 0.17
FCF / Share -0.12 OCF / Share -0.12
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.41% FCF Conversion 92.02%
SBC-Adj. FCF -7.55 M Growth Momentum -3.85

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 9.10 M 3.45 M 1.95 M 171,169.0 178,146.0
Net Income -3.61 M -12.32 M -11.86 M -10.00 M -9.95 M
EPS (Diluted) -0.09 -0.46 -0.65 -0.63 —
Gross Profit 5.14 M 1.08 M 456,517.0 -70,794.0 -97,749.0
Operating Income -4.23 M -11.89 M -11.96 M -10.03 M -10.22 M
EBITDA — — — — —
R&D Expenses 4.98 M 5.07 M 6.94 M 4.93 M 3.93 M
SG&A Expenses 7.38 M 7.90 M 6.93 M 6.98 M —
D&A 261,679.0 246,791.0 199,266.0 118,620.0 80,748.0
Interest Expense — — — 3,053.0 -3,053.0
Income Tax — — — — -271,122.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10.79 M 5.37 M 8.10 M 12.82 M 7.94 M
Total Liabilities 3.71 M 4.55 M 1.85 M 3.22 M 1.38 M
Shareholders' Equity 7.07 M 822,013.0 6.25 M 9.60 M 6.55 M
Total Debt — — — — 1.01 M
Cash & Equivalents 6.57 M 1.46 M 5.32 M 8.16 M 6.90 M
Current Assets 10.23 M 4.63 M 7.31 M 12.18 M 7.29 M
Current Liabilities 2.30 M 2.21 M 1.79 M 3.10 M 1.18 M